Brachytherapy seed
US6746661B2 · kind B2 · utility
122Cited by
34References
50Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 18, 2001 |
| Grant date | Jun 8, 2004 |
| Priority date | — |
| Expiry date | Jun 6, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/906
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A radiopaque brachytherapy seed for implantation into a subject includes a biocompatible component, a therapeutically active component including a non-radioactive drug, and a radiopaque marker. The biocompatible component is (a) physically associated with a therapeutically active component and (b) in contact with the radiopaque marker. The brachytherapy seed has a size and shape suitable for passing through the bore of a needle having an interior diameter of less than about 2.7 millimeters (10 gauge).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.